Bölüm notları
Corey and Grant sit down with Mammoth Biosciences co-founder and CEO Dr. Trevor Martin to explain how CRISPR is moving from a laboratory tool toward one-time medicines.
Trevor breaks down how Mammoth searches massive biological datasets for new CRISPR systems, why AI is useful but still constrained by missing clinical data, and what it would take to build a feedback loop between AI models, wet labs, and human trials. The conversation also covers personalized medicine, the economics of one-time cures, organoids, and why a medical breakthrough may be the clearest way for AI to prove its value…
Web sitesi: podcasters.spotify.com

